Skip to main content
. 2012 Aug 6;30(26):3194–3201. doi: 10.1200/JCO.2012.41.7071

Fig 2.

Fig 2.

(A) Cumulative incidence of neutrophil engraftment by treatment arm. (B) Cumulative incidence of platelet engraftment by treatment arm. (C) Cumulative incidence of grade 2 to 4 acute graft-versus-host disease (GVHD) by treatment arm. (D) Cumulative incidence of chronic GVHD by treatment arm. IST, immune suppression therapy; TCD, T-cell depletion.